Status:
WITHDRAWN
Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy
Lead Sponsor:
Sooft Italia
Conditions:
Primary Open Angle Glaucoma
Intraocular Pressure
Eligibility:
All Genders
30-70 years
Brief Summary
Elevated intraocular pressure is still the main risk factor for development and progression of glaucoma. Several drugs exist on the market that may decrease IOP in glaucomatous patients. However, some...
Eligibility Criteria
Inclusion
- Age: 30-70 Years
- Sex: both
- Pathology: POAG
- Characteristics: Target pressure not achieved with current treatments
Exclusion
- Concomitant ocular pathologies
- Previous ocular surgery
- Known hypersensitivity to any of the components in the KRONEK tablets
- Concomitant participation in other trials
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00864578
Start Date
April 1 2009
End Date
June 1 2009
Last Update
June 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Department of the University Clinic
Bari, Italy, I-70124